Ionis Pharmaceuticals Inc. Stock
We can see a decrease in the price for Ionis Pharmaceuticals Inc.. Compared to yesterday it has lost -€0.940 (-2.030%).
With 62 Buy predictions and 1 Sell predictions Ionis Pharmaceuticals Inc. is one of the favorites of our community.
As a result the target price of 80 € shows a very positive potential of 78.13% compared to the current price of 44.91 € for Ionis Pharmaceuticals Inc..
For the coming years our community has positive and negative things to say abot the Ionis Pharmaceuticals Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.
Pros and Cons of Ionis Pharmaceuticals Inc. in the next few years
Pros
?
S********** s********
?
C******** o* t** e**********
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Ionis Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Ionis Pharmaceuticals Inc. | -2.030% | -9.692% | -36.406% | 19.220% | -33.917% | 19.125% | 43.391% |
| Ligand Pharmaceuticals | -1.540% | -3.759% | -7.246% | 118.803% | 54.217% | 316.260% | 167.056% |
| United Therapeutics | -1.560% | -3.421% | -5.275% | 86.343% | 5.055% | 103.398% | 189.613% |
| Novocure Ltd | -1.670% | -17.160% | -5.020% | 26.811% | 13.498% | -56.698% | -90.089% |
Comments
Ionis Pharmaceuticals (IONS) had its price target lowered by Wells Fargo & Company from $100.00 to $95.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for IONS provided by MarketBeat
Ionis Pharmaceuticals (IONS) had its price target lowered by HC Wainwright from $125.00 to $115.00. They now have a "buy" rating on the stock.
Show more
Ratings data for IONS provided by MarketBeat
Ionis Pharmaceuticals (IONS) had its "buy" rating reaffirmed by HC Wainwright.
Show more
Ratings data for IONS provided by MarketBeat